Identification of genes related to the effects of bicalutamide and zoladex on benign prostatic hyperplasia
{{output}}
Existing research indicates that bicalutamide and zoladex show significant potential in treating prostate cancer. However, in the clinical application of treating benign prostatic hyperplasia (BPH), it is limited due to relatively severe side effects, and the ... ...
